Nature Communications (May 2022)

Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide

  • Yongxiang Zhao,
  • Kasturi Roy,
  • Pietro Vidossich,
  • Laura Cancedda,
  • Marco De Vivo,
  • Biff Forbush,
  • Erhu Cao

DOI
https://doi.org/10.1038/s41467-022-30407-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

Loop diuretics including bumetanide inhibit Na+-K+-Cl−-cotransporters (NKCCs) and are used for the treatment of edema and hypertension. Here, Zhao et. al. report structures of NKCC1 with bumetanide bound, revealing its mechanism of action that would facilitate design of novel diuretics.